Anti-CD20 therapies have transformed the treatment landscape of Multiple Sclerosis (MS), offering highly effective disease control through targeted B-cell depletion. As these therapies are increasingly used early in the disease course and maintained over many years, understanding their long-term efficacy, safety, and optimal use has become essential for clinical practice.
In this webinar, Celia Oreja-Guevara and Patrick Vermersch review the latest evidence on anti-CD20 therapies, including ocrelizumab, ofatumumab, rituximab, and ublituximab. Drawing from pivotal clinical trials, extension...
This expert panel discussion explores the current challenges in understanding and managing neuromyelitis optica spectrum disorder (NMOSD). Bringing together clinical perspectives, the conversation highlights gaps in pathophysiology, limitations in monitoring tools, and ongoing uncertainties in long-term treatment strategies. Despite advances in biomarkers and therapies, real-world decision-making remains largely driven by clinical experience.
Key Insights from the Lecture:
Antibodies alone are not sufficient to cause disease
Clinical context remains essential
T cells play a...
Family planning is a central concern for women living with multiple sclerosis, as the disease often affects patients during their reproductive years. Questions around pregnancy, treatment safety, and postpartum relapse risk require careful, individualized planning. With the right multidisciplinary approach and treatment strategies, pregnancy can be safely managed while minimizing risks for both mother and child.
Key Insights from the Lecture:
Family planning is a key concern in MS care
Pregnancies are not always planned
Planning pregnancy reduces risks
Multidisciplinary...
In this short interview, Jelena Drulović reflects on the value of interactive, discussion-based education in multiple sclerosis care.
Watch the interview
Why is interactive, discussion-based education essential for improving multiple sclerosis care?
Jelena Drulović explains how active engagement between experts and clinicians enhances knowledge transfer and translates scientific discussion into better clinical practice.
Key points discussed include:
Why interactive, discussion-based education strengthens MS care
The value of direct exchange between experts and practicing...
In this short video interview, Celia Oreja-Guevara reflects on the challenges facing the new generation of neurologists. In a time when information is instantly accessible online and artificial intelligence is increasingly used, she emphasises the importance of independent medical education and critical thinking.
Watch the interview
Why is independent medical education especially important in the age of AI and online information?
Celia Oreja-Guevara highlights that while today’s generation has rapid access to information, true medical learning requires more than searching online....
In this short video interview, Celia Oreja-Guevara, ParadigMS President, shares her vision for the next five years of ParadigMS. Celia outlines an ambition to develop collaborative scientific projects and strengthen the foundation’s presence within the European neurological community.
Watch the interview
Celia highlights:
The ambition to develop a joint European scientific project
Strengthening collaboration across countries and specialisations
Moving beyond review articles toward more dissemination of original research
Publishing work that reflects real clinical practice...
Free subscriptions to ParadigMS are reserved for healthcare practitioners. If you are a representative of the industry please contact us on learning@paradigms.foundation and we would advise you how to get the access to the material.
If you subscribe as a healthcare practitioner and it is proven that you are not a healthcare practitioner, we will cancel your subscription immediately.
ParadigMS is designed specifically for healthcare practitioners, with content and language tailored to their professional needs. While patients cannot subscribe directly, we encourage you to consult your healthcare provider for relevant insights and updates that may benefit you.
Subscribing to ParadigMS’s e-platform gives you access to up-to-date information and valuable learning materials on multiple sclerosis and NMO, along with expert insights and the latest innovations in the field. It’s an essential resource for staying informed and enhancing your knowledge in MS care.
Yes, you can financially support ParadigMS! We welcome donations to help us continue our mission of advancing multiple sclerosis education and research. Your contribution directly supports the creation of educational resources, expert discussions, and innovative projects in MS care. Visit our donation page to learn more about how you can make a difference: ParadigMS Donate.